Elite Pharma Inc
(ELTP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2005 | 03-2004 | 03-2003 | 03-2002 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,907 | -6,514 | -4,061 | -1,775 | -13,965 |
| Depreciation Amortization | 356 | 333 | 311 | 267 | 194 |
| Accounts receivable | -142 | -149 | 561 | -444 | -81 |
| Other Working Capital | -554 | 596 | 728 | -574 | -215 |
| Other Operating Activity | 1,363 | 2,076 | -111 | 957 | 12,161 |
| Operating Cash Flow | $-4,884 | $-3,658 | $-2,574 | $-1,569 | $-1,906 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 100 | -100 | N/A |
| PPE Investments | -28 | -399 | -680 | -347 | -274 |
| Purchase Sale Intangibles | N/A | -17 | -70 | -7 | -31 |
| Other Investing Activity | 316 | -96 | 111 | -85 | 89 |
| Investing Cash Flow | $288 | $-495 | $-469 | $-532 | $-185 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400 | N/A | N/A | 375 | N/A |
| Debt Repayment | -460 | -215 | -205 | -120 | -115 |
| Common Stock Issued | 585 | 3,209 | 66 | 1,401 | 5,566 |
| Common Stock Repurchased | N/A | N/A | -307 | N/A | N/A |
| Other Financing Activity | 5,868 | 0 | -100 | 0 | 0 |
| Financing Cash Flow | $6,393 | $2,994 | $-546 | $1,656 | $5,451 |
| Beginning Cash Position | 2,105 | 3,264 | 6,852 | 7,297 | 3,937 |
| End Cash Position | 3,902 | 2,105 | 3,264 | 6,852 | 7,297 |
| Net Cash Flow | $1,797 | $-1,159 | $-3,588 | $-444 | $3,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,884 | -3,658 | -2,574 | -1,569 | -1,906 |
| Capital Expenditure | -28 | -399 | -680 | -347 | -274 |
| Free Cash Flow | -4,911 | -4,057 | -3,253 | -1,916 | -2,180 |